无创通气与经鼻高流量氧疗对拔管后吸气努力与潮气量的生理学比较:随机交叉试验
本研究为前瞻性生理学研究,纳入拔管失败高危患者(>65岁或存在基础心脏或呼吸系统疾病),在计划拔管后按随机交叉顺序接受预防性无创通气与经鼻高流量氧疗,随后给予标准氧疗。通过计算每分钟简化食管压-时间乘积(sPTPes)评估吸气努力,并利用电阻抗断层成像估算潮气量、通气分布与均匀性。共20例患者纳入分析,无创通气期间吸气努力低于经鼻高流量氧疗(sPTPes 196 cmH2O s/min [116-234] vs 220 [178-327],p<0.001),潮气量大于经鼻高流量氧疗(8.4 mL/kg预测体重 [6.7-9.9] vs 6.9 [5.3-8.6],p=0.005)。无创通气较经鼻高流量氧疗在背侧区域通气有非显著性增加。作者认为无创通气预防再插管的临床获益可能由这些生理学效应介导。
要点
- 拔管失败高危患者(>65岁或存在基础心脏或呼吸系统疾病)拔管后预防性无创通气较经鼻高流量氧疗显著降低吸气努力:sPTPes 196 cmH2O s/min [116-234] vs 220 [178-327],p<0.001。
- 同一人群中,无创通气较经鼻高流量氧疗显著增加潮气量:8.4 mL/kg预测体重 [6.7-9.9] vs 6.9 [5.3-8.6],p=0.005。
- 无创通气较经鼻高流量氧疗在背侧区域通气有非显著性增加。
- 作者认为无创通气预防再插管的临床获益可能由降低吸气努力和增加潮气量这些生理学效应介导。
- 临床实践指南推荐拔管失败高危患者拔管后立即预防性使用无创通气而非经鼻高流量氧疗。
适用人群与场景
- 拔管失败高危患者:年龄>65岁或存在基础心脏或呼吸系统疾病,计划拔管后纳入。
诊断标准与关键阈值
- 拔管失败高危定义:年龄>65岁或存在基础心脏或呼吸系统疾病。
处置流程与药物剂量
- 计划拔管后按随机交叉顺序接受预防性无创通气与经鼻高流量氧疗,随后给予标准氧疗。
研究设计与关键结果
- 研究类型:前瞻性生理学研究,随机交叉设计,20例患者纳入分析。
- 人群:拔管失败高危患者(>65岁或存在基础心脏或呼吸系统疾病)。
- 干预与对照:计划拔管后预防性无创通气 vs 经鼻高流量氧疗,随机交叉顺序,随后标准氧疗。
- 主要终点:吸气努力以sPTPes评估,无创通气低于经鼻高流量氧疗(196 cmH2O s/min [116-234] vs 220 [178-327],p<0.001)。
- 关键次要终点:潮气量无创通气大于经鼻高流量氧疗(8.4 mL/kg预测体重 [6.7-9.9] vs 6.9 [5.3-8.6],p=0.005);背侧区域通气无创通气较经鼻高流量氧疗有非显著性增加。
证据类型、等级与局限
- 证据类型:前瞻性生理学研究,随机交叉试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 临床实践指南推荐拔管失败高危患者拔管后立即预防性使用无创通气而非经鼻高流量氧疗。
- 作者认为无创通气预防再插管的临床获益可能由降低吸气努力和增加潮气量这些生理学效应介导。
指南或共识出处
- 临床实践指南(原文未注明具体指南名称)推荐拔管失败高危患者拔管后立即预防性使用无创通气而非经鼻高流量氧疗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Extubation failure leading to reintubation is associated with high mortality. In patients at high-risk of extubation failure, clinical practice guidelines recommend prophylactic non-invasive ventilation (NIV) over high-flow nasal oxygen (HFNO) immediately after extubation. However, the physiological effects supporting the beneficial effect of NIV have been poorly explored. We hypothesized that NIV may reduce patient inspiratory efforts to a greater extent than HFNO after extubation.
METHODS: In a prospective physiological study, patients at high-risk of extubation failure (> 65 years old or underlying cardiac or respiratory disease) were included to receive after planned extubation prophylactic NIV and HFNO in a randomized crossover order, followed by standard oxygen. Inspiratory efforts were assessed by calculation of the simplified esophageal pressure-time-product per minute (sPTPes in cmH2O s/min). Tidal volumes, distribution and homogeneity of ventilation were estimated using electrical impedance tomography.
RESULTS: Twenty patients were retained in the analysis. Inspiratory efforts were lower with NIV than with HFNO (sPTPes 196 cm H2O s/min [116-234] vs. 220 [178-327], p < 0.001) whereas tidal volumes were larger with NIV than with HFNO (8.4 mL/kg of predicted body weight [6.7-9.9] vs. 6.9 [5.3-8.6], p = 0.005). There was a non-significant increase in dorsal region ventilation under NIV compared to HFNO.
CONCLUSIONS: In patients at high-risk of extubation failure, prophylactic NIV significantly decreased inspiratory efforts with increased tidal volumes compared to HFNO. The clinical benefits of NIV to prevent reintubation in patients at high-risk may be mediated by these physiological effects. Trial registration Clinicaltrials.gov: ID NCT04036175), retrospectively registered 17 June 2019.
参考来源
- Arrive F, Le Pape S, Bruhn A, et al. Physiological comparison of noninvasive ventilation and high-flow nasal oxygen on inspiratory efforts and tidal volumes after extubation: a randomized crossover trial. Crit Care. 2025. PMID: 40341100. doi:10.1186/s13054-025-05366-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。